In recurrent prostate cancer, imaging the GRP-R may be beneficial in patients with negative or inconclusive [18F]Fluoroethylcholine imaging [6] and trials are undergoing to compare its role over [68Ga]Ga-PSMA-11 [7]. This evidence concerns the gene FOLH1 and Familial prostate cancer.